Video

Examining Response Rates in MSI-H and NTRK Fusion GI Cancers

Author(s):

Luis A. Diaz, M.D.

Luis A. Diaz, M.D., head of the division of Solid Tumors at Memorial Sloan Kettering Cancer Center, discusses response rates in patients with microsatellite instability-high (MSI-H) or NTRK fusion gastrointestinal (GI) cancers.

Luis A. Diaz, M.D., head of the division of Solid Tumors at Memorial Sloan Kettering Cancer Center, discusses response rates in patients with microsatellite instability-high (MSI-H) or NTRK fusion gastrointestinal (GI) cancers.

Finding these biomarkers in patients with GI cancers can be particularly important, as it can help choose a treatment plan that can have a dramatic response in this group of patients.

Related Videos
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Image of a man with white hair and a white goatee.
Image of a woman with brown wavy hair, wearing a navy blue top.
Image of a man wearing a suit with a red bowtie.
Image of a man with rectangular glasses and a goatee.
Image of a woman with glasses and dark hair.
Image of a woman wearing a red tank top.
Image of a woman with a brown hair tied into a bun.
Related Content
Illuatration of large intesines inside body.
October 5th 2024

Non-Surgical Options May Maintain Relapse-Free Survival in Rectal Cancer Subset

Ariana Pelosci
Distance relapse-free survival was maintained in patients with pMMR locally advanced rectal cancer through non-operative management of the disease.
Teri Greige with medals
February 16th 2023

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
Image of Ann Wilson with sister Nancy Wilson - Jamie McCarthy via Getty Images
September 27th 2024

Ann Wilson of Heart Returns After Chemo, Ryan Reynolds Visits Young Patient and More

Alex Biese Ashley Chan
From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022

‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Illustration of large intestines.
September 19th 2024

Braftovi Regimen Is Promising in Metastatic Colorectal Cancer

Jason Broderick
In patients with BRAF V600E-mutant metastatic colorectal cancer, a combination of Braftovi, Erbitux and chemotherapy showed promising antitumor activity.
Picture of Dr. Guillermo Garcia-Manero
September 18th 2024

Why Transfusion Independence Matters for Patients With MDS

Alex Biese
An expert explained the burden that red blood cell transfusions can place on patients with MDS.